PAVmed Inc. — Director's Dealing 2018

Feb 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-02-14

Reporting Person: Weild IV David (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-14	Employee Stock Option (Right to Buy)	$2.01	A	100000	Acquired	2028-02-14	Common Stock (100000)	Direct

Footnotes

F1: The option vests in 12 equal quarterly installments commencing on March 31, 2018.